NEW YORK (GenomeWeb News) — Third Wave Technologies today said third-quarter revenues grew 24 percent as R&D spending rose 68 percent and its net loss widened 25 percent. 
 
Total receipts for the three months ended Sept. 30 increased to $8.2 million from $6.6 million year over year.
 
Revenue from clinical products rose 25 percent to $6.7 million, while receipts from research products increased 19 percent to $1.4 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.